Beta Bionics Shares Edge Higher After Q4 Revenue Jumps 57%, Full-Year Sales Top $100 Million
Shares of Beta Bionics, Inc. (Nasdaq: BBNX) were trading modestly higher in late morning U.S. trading on Wednesday, up about...
Shares of Beta Bionics, Inc. (Nasdaq: BBNX) were trading modestly higher in late morning U.S. trading on Wednesday, up about...
Moderna Inc. (NASDAQ: MRNA) reported fourth-quarter 2025 revenue of $678 million, a 30% decrease from $966 million in the same...
Karyopharm Therapeutics Inc (NASDAQ: KPTI) Shares closed at $6.31 on the Nasdaq in the most recent session, reflecting an intraday...
Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year increase driven by demand for...
Shares of AptarGroup, Inc. (ATR) advanced modestly following the release of fourth-quarter and full-year 2025 results on February 5, 2026,...